Pulike Biological Engineering Inc
SSE:603566
Pulike Biological Engineering Inc
Total Assets
Pulike Biological Engineering Inc
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pulike Biological Engineering Inc
SSE:603566
|
Total Assets
¥3.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Total Assets
¥31.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Total Assets
¥18B
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
18%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Total Assets
¥50.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
19%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Total Assets
¥5.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Total Assets
¥7.1B
|
CAGR 3-Years
96%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Pulike Biological Engineering Inc
Glance View
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.
See Also
What is Pulike Biological Engineering Inc's Total Assets?
Total Assets
3.1B
CNY
Based on the financial report for Sep 30, 2024, Pulike Biological Engineering Inc's Total Assets amounts to 3.1B CNY.
What is Pulike Biological Engineering Inc's Total Assets growth rate?
Total Assets CAGR 5Y
11%
Over the last year, the Total Assets growth was -7%. The average annual Total Assets growth rates for Pulike Biological Engineering Inc have been 14% over the past three years , 11% over the past five years .
You don't have any saved screeners yet